Signaling pathways associated with interleukins 12 and 23 and epigenetic mechanism of sequential-specific regulation of expression of related genes by miRNAs as molecular markers for assessing the potential of anti-cytokine therapies
The molecular targeted therapy is focused on blocking the activity of specific cytokines and the signalling cascades they activate. In the treatment of psoriasis, this type of therapy is based on treatment with anti-tumor necrosis factor drugs, anti-IL-12/23, anti-IL-17, inhibitors of JAK kinases. I...
Uloženo v:
| Vydáno v: | Przegląd dermatologiczny Ročník 106; číslo 1; s. 71 - 80 |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Journal Article |
| Jazyk: | angličtina |
| Vydáno: |
Poznan
Termedia Publishing House
01.01.2019
|
| Témata: | |
| ISSN: | 0033-2526, 2084-9893 |
| On-line přístup: | Získat plný text |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|
| Abstract | The molecular targeted therapy is focused on blocking the activity of specific cytokines and the signalling cascades they activate. In the treatment of psoriasis, this type of therapy is based on treatment with anti-tumor necrosis factor drugs, anti-IL-12/23, anti-IL-17, inhibitors of JAK kinases. Interleukins 12 and 23 interact with the receptors to trigger the JAK/STAT signalling pathway, the end products of which are other cytokines, e.g. tumour necrosis factor, IL-17, interferon g. These cytokines affect both IL-12/23 shaping their concentration profile, as well as trigger other signalling paths themselves. Gene expression is regulated by DNA methylation, miRNA molecules and histone protein modifications. The miRNA seems to be a promising model of a molecular marker system. Understanding the interrelationships between individual signalling pathways associated with IL-12 and IL-23 and the role of epigenetic mechanisms to regulate their expression is important for the development and implementation of new diagnostic-therapeutic schemes and the further development of personalized medicine. |
|---|---|
| AbstractList | The molecular targeted therapy is focused on blocking the activity of specific cytokines and the signalling cascades they activate. In the treatment of psoriasis, this type of therapy is based on treatment with anti-tumor necrosis factor drugs, anti-IL-12/23, anti-IL-17, inhibitors of JAK kinases. Interleukins 12 and 23 interact with the receptors to trigger the JAK/STAT signalling pathway, the end products of which are other cytokines, e.g. tumour necrosis factor, IL-17, interferon g. These cytokines affect both IL-12/23 shaping their concentration profile, as well as trigger other signalling paths themselves. Gene expression is regulated by DNA methylation, miRNA molecules and histone protein modifications. The miRNA seems to be a promising model of a molecular marker system. Understanding the interrelationships between individual signalling pathways associated with IL-12 and IL-23 and the role of epigenetic mechanisms to regulate their expression is important for the development and implementation of new diagnostic-therapeutic schemes and the further development of personalized medicine. |
| Author | Mazurek, Urszula Wcisło-Dziadecka, Dominika L. Grabarek, Beniamin O. |
| Author_xml | – sequence: 1 givenname: Beniamin O. surname: Grabarek fullname: Grabarek, Beniamin O. – sequence: 2 givenname: Dominika L. surname: Wcisło-Dziadecka fullname: Wcisło-Dziadecka, Dominika L. – sequence: 3 givenname: Urszula surname: Mazurek fullname: Mazurek, Urszula |
| BookMark | eNo9UstuGyEUHVWpVCftsnukrscdXmNYRlEfkaJW6mONMFzGOGOYAlbiT-5fFOyoqwOXc885utzr7irEAF33Hg9rjjH7aNOaDFiuBWWMv-pWZBCsl0LSq241DJT2hJPxTXed834YRkkwWXV_f_op6NmHCS267J70KSOdczReF7DoyZcd8qFAmuH46ENGmCAdLCL0DLD4CQIUb9ABzE4Hnw8oOpThzxFC8Xru8wLGu0pIMB1nXXwMjQHPS4KcX24J5rNfE8toe0IH_-PbbYuCDnEGUxsTOuj0CCkjF1PL2Lpr7LIDtMRycWtaup56cyqx5oX2nPTiIb_tXjs9Z3j3gjfd78-fft197R--f7m_u33oDeFj6RkZDZFm6ziBkTnKNgas3GpmLRNMGrnFjAhLR7uxFDjAiMUAjFtCpMDW0Zvu_qJro96rJfka-6Si9upciGlSOtWBzaCEAwMaO2CSMANccEaaFavAKRdV68NFa0mxDjQXtY_HVP8rK0KGjZR0I8fK6i8sk2LOCdx_VzyothnKJtU2Q503g_4D4g2zow |
| ContentType | Journal Article |
| Copyright | 2019. This work is published under http://creativecommons.org/licenses/by-nc-sa/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
| Copyright_xml | – notice: 2019. This work is published under http://creativecommons.org/licenses/by-nc-sa/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
| DBID | AAYXX CITATION 3V. 7X7 7XB 88E 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR BYOGL CCPQU DWQXO FYUFA GHDGH K9. M0S M1P PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI DOA |
| DOI | 10.5114/dr.2019.83445 |
| DatabaseName | CrossRef ProQuest Central (Corporate) Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) ProQuest Hospital Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials - QC ProQuest Central (New) East Europe, Central Europe Database ProQuest One Community College ProQuest Central Korea Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Health & Medical Complete (Alumni) ProQuest Health & Medical Collection Medical Database ProQuest Central Premium ProQuest One Academic (New) Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic (retired) ProQuest One Academic UKI Edition DOAJ Directory of Open Access Journals |
| DatabaseTitle | CrossRef Publicly Available Content Database ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Central ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Health & Medical Research Collection ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest One Academic Eastern Edition East Europe, Central Europe Database ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) |
| DatabaseTitleList | Publicly Available Content Database |
| Database_xml | – sequence: 1 dbid: DOA name: Directory of Open Access Journals (DOAJ) url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: BYOGL name: East Europe, Central Europe Database url: https://search.proquest.com/eastcentraleurope sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 2084-9893 |
| EndPage | 80 |
| ExternalDocumentID | oai_doaj_org_article_8fecea1fe4924ce585429ba444295358 10_5114_dr_2019_83445 |
| GroupedDBID | 2NK 53G 7X7 88E 8FI 8FJ AAYXX ABDBF ABUWG ACUHS ADBBV AFFHD AFKRA AHMBA ALMA_UNASSIGNED_HOLDINGS BAWUL BCNDV BENPR BPHCQ BVXVI BYOGL CCPQU CITATION DIK EBD EOJEC ESX F5P FYUFA GROUPED_DOAJ HMCUK IPNFZ M1P OBODZ OK1 PHGZM PHGZT PIMPY PJZUB PPXIY PQQKQ PROAC PSQYO RIG RNS TUS UKHRP Y2W 3V. 7XB 8FK AZQEC DWQXO K9. PKEHL PQEST PQUKI |
| ID | FETCH-LOGICAL-c256t-426c29cbf52e64f347ced9ba4dd4849c9b1428d36d7d3e5ee6180e45d22981df3 |
| IEDL.DBID | PIMPY |
| ISICitedReferencesCount | 2 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000461734000006&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 0033-2526 |
| IngestDate | Tue Oct 14 19:05:13 EDT 2025 Sat Nov 29 14:54:46 EST 2025 Wed Nov 05 06:38:19 EST 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 1 |
| Language | English |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c256t-426c29cbf52e64f347ced9ba4dd4849c9b1428d36d7d3e5ee6180e45d22981df3 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 |
| OpenAccessLink | https://www.proquest.com/publiccontent/docview/2207993796?pq-origsite=%requestingapplication% |
| PQID | 2207993796 |
| PQPubID | 1286336 |
| PageCount | 10 |
| ParticipantIDs | doaj_primary_oai_doaj_org_article_8fecea1fe4924ce585429ba444295358 proquest_journals_2207993796 crossref_primary_10_5114_dr_2019_83445 |
| PublicationCentury | 2000 |
| PublicationDate | 2019-01-01 |
| PublicationDateYYYYMMDD | 2019-01-01 |
| PublicationDate_xml | – month: 01 year: 2019 text: 2019-01-01 day: 01 |
| PublicationDecade | 2010 |
| PublicationPlace | Poznan |
| PublicationPlace_xml | – name: Poznan |
| PublicationTitle | Przegląd dermatologiczny |
| PublicationYear | 2019 |
| Publisher | Termedia Publishing House |
| Publisher_xml | – name: Termedia Publishing House |
| SSID | ssj0069212 ssib026971654 |
| Score | 2.0880063 |
| Snippet | The molecular targeted therapy is focused on blocking the activity of specific cytokines and the signalling cascades they activate. In the treatment of... |
| SourceID | doaj proquest crossref |
| SourceType | Open Website Aggregation Database Index Database |
| StartPage | 71 |
| SubjectTerms | anti-cytokine therapies Cytokines DNA methylation epigenetic Epigenetics Gene expression inflammatory process molecular marker signaling pathways TNF inhibitors |
| SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1La9wwEBYllNJL6ZNum5Q5lN5MbEmW7WNaEnJol9IH5CZsaRQMsXexnbb7k_svOmN5w0IPvfRkbGxr8Iw130gz3wjxVjpDTkGliQu6SXThQlJKdEkqg6qZezJEkqSPxXpdXl1Vnw9afXFOWKQHjh_utAzosM4CaooUHBK6pRm0qbWmQ67yucyXUM9BMEWWJA0zI7GjjHOyqeK-Z-xclksT2TYJbOhTz6ygGVmM0lzTdOCdZhL_v-bo2fFcPBaPFsQIZ1HSJ-Ie9k_Fg0_Lnvgz8ftre81our8Gbi_8s96NUC8fHT3wQiswKcRwg7ecEAOZhLr3INV8wC3zcXIpI3TIZcDt2MEmQMyxpv__JuFqTM4ogiE2ridV8h34a0minc_mohgaj182QrODrv2yPmNRoNu34IWOk4GGEQgps4z8NIlNGBS2mymOxu8ibbeJ200bkhchlohRRP9cfL84__bhMlkaOCSOkNSUkPd3snJNyCUaHRSZAnpWnve61JWreAWq9Mr4wivMEU1WpqhzL2VFODqoF-Ko3_T4UkCVV6ZpQkmGZXQWdO1SVWeFp-gNg0zlSrzbK85uI0-HpfiGNWz9YFnDdtbwSrxntd7dxPTa8wUyOrsYnf2X0a3E8d4o7PLPj1bKtGC0V5lX_2OM1-IhSx2Xe47F0TTc4om4735M7Ti8mc39D8uWBq4 priority: 102 providerName: Directory of Open Access Journals |
| Title | Signaling pathways associated with interleukins 12 and 23 and epigenetic mechanism of sequential-specific regulation of expression of related genes by miRNAs as molecular markers for assessing the potential of anti-cytokine therapies |
| URI | https://www.proquest.com/docview/2207993796 https://doaj.org/article/8fecea1fe4924ce585429ba444295358 |
| Volume | 106 |
| WOSCitedRecordID | wos000461734000006&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVAON databaseName: Directory of Open Access Journals (DOAJ) customDbUrl: eissn: 2084-9893 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0069212 issn: 0033-2526 databaseCode: DOA dateStart: 20090101 isFulltext: true titleUrlDefault: https://www.doaj.org/ providerName: Directory of Open Access Journals – providerCode: PRVPQU databaseName: East Europe, Central Europe Database customDbUrl: eissn: 2084-9893 dateEnd: 20220331 omitProxy: false ssIdentifier: ssj0069212 issn: 0033-2526 databaseCode: BYOGL dateStart: 20090301 isFulltext: true titleUrlDefault: https://search.proquest.com/eastcentraleurope providerName: ProQuest – providerCode: PRVPQU databaseName: Health & Medical Collection customDbUrl: eissn: 2084-9893 dateEnd: 20220331 omitProxy: false ssIdentifier: ssj0069212 issn: 0033-2526 databaseCode: 7X7 dateStart: 20090301 isFulltext: true titleUrlDefault: https://search.proquest.com/healthcomplete providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Central customDbUrl: eissn: 2084-9893 dateEnd: 20220331 omitProxy: false ssIdentifier: ssj0069212 issn: 0033-2526 databaseCode: BENPR dateStart: 20090301 isFulltext: true titleUrlDefault: https://www.proquest.com/central providerName: ProQuest – providerCode: PRVPQU databaseName: Publicly Available Content Database customDbUrl: eissn: 2084-9893 dateEnd: 20220331 omitProxy: false ssIdentifier: ssj0069212 issn: 0033-2526 databaseCode: PIMPY dateStart: 20090301 isFulltext: true titleUrlDefault: http://search.proquest.com/publiccontent providerName: ProQuest |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3fi9NAEF68VsQXfx9Wz7IP4ltostn8epI7uUPBK-VUqE8h2Z0tgUtSk5zaP9n_wpnsRgXBJ59CmzSZ0q8z387OfMPYS6FiDAqh7ykjS08mynipAOX5woQFaU8aK5L0Plmv0-0227j26N6VVU4-cXTUVu2Z6rbRCa90qyhjvhLCTyiyZvHr_RePZkjRXqsbqHHE5iS8lc7YfPPucvN5wpeISS-Jwqf11HFmd0PtPLNIxFaDEymIXGnSCg0QR6GkTqc_YtYo7f-X5x7D0cX9__tFHrB7jpbyU4ujh-wWNI_YnUu38f6Y_fhQ7YiyNztOM4y_FYeeF-6XBc0pm8tJeaK7hhuquuGB4EWjuQjHA-xJ9JP6JXkN1Gtc9TVvDbeF3Ohkrj1q-aSyJd7Bzo0Uoyvgu6vUHV-NnTf4PLpZz8sDr6ur9SmZwutpzi-vqeKo6znScbKRPo1mI9Hl-3awT6N7IaQqTx2GFu0FbvvQKuifsE8X5x_fvPXclAhPIV0bPKQYSmSqNJGAWJoQ8QY6KwuptUxlpjJKc6U6jHWiQ4gA4iD1QUZaiAzJugmP2axpG3jKeBZlcVmaFNEby8DIQvlhESQal4hghC8W7NWEg3xvxUByXEQRYHLd5QSYfATMgp0RSn5dRBre4xttt8udS8hTAwqKwIDENbACXLchN0C7JR6iMEoX7GQCUO4cS5__xsuzf59-zu6SPTZbdMJmQ3cDL9ht9XWo-m7JjpJtsmTzs_P15mo5JiKW7t_yE8q8JXo |
| linkProvider | ProQuest |
| linkToHtml | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V3JbtRAEG2FgCAX1iAGAtQBuFmx2-3tgFBYokSZjBAEaW7G7q4eWcqMB3uSMD_Ff_EXVLntgITELQdOlrd2yX5Vr6tdixAvpI6JFELf01aVnkq09VKJ2vOlDQuuPWldkaRxMpmk02n2cUP8GHJhOKxysImdoTa15jXyXSn9hLk0i98sv3ncNYr_rg4tNBwsjnB9QS5b-_rwPX3fl1Lufzh5d-D1XQU8TfS-8oiStMx0aSOJsbIhyYcmKwtljEpVpjNeFklNGJvEhBghxkHqo4qMlBlN7mxI414T18mOJxxClkwv6VvGXI-J6dkxQZy5v62uX1okY1fjk6Y4atdwLdKAcBoqzqT6gxO71gF_MUNHd_t3_rcXdVfc7ifWsOc04Z7YwMV9cfO4Dx14IH5-rmbsdCxmwF2YL4p1C0WPTTTA69HAtTOaUzzjuCEIJBQLAzLsNrjksqWc8Qlz5Gzpqp1DbcGFopOZPPU4aZUDr6DBWd8Uja_A732scbfX5Q7R83iwFso1zKtPkz0WBeZDp2KYc8xU0wI5FCwj301i01QdlvXKPY3HIqWoPL1e1SQvgsukq7DdFl-u5EU_FJuLeoGPBGRRFpelTUn_YhVYVWg_LILEkJOLVvpyJF4NSMuXrpxJTm4gQzI3Tc6QzDtIjsRbxuHlRVyFvDtQN7O8N2p5alFjEVhU5MVrJM-TtILkVrSJwigdiZ0BonlvGtv8Nz4f__v0c3Hr4OR4nI8PJ0dPxBbL5ta-dsTmqjnDp-KGPl9VbfOs00IQX68azb8AWRdyew |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Signaling+pathways+associated+with+interleukins+12+and+23+and+epigenetic+mechanism+of+sequential-specific+regulation+of+expression+of+related+genes+by+miRNAs+as+molecular+markers+for+assessing+the+potential+of+anti-cytokine+therapies&rft.jtitle=Przegla%CC%A8d+dermatologiczny&rft.au=Grabarek%2C+Beniamin+O.&rft.au=Wcis%C5%82o-Dziadecka%2C+Dominika+L.&rft.au=Mazurek%2C+Urszula&rft.date=2019-01-01&rft.issn=0033-2526&rft.volume=106&rft.issue=1&rft.spage=71&rft.epage=80&rft_id=info:doi/10.5114%2Fdr.2019.83445&rft.externalDBID=n%2Fa&rft.externalDocID=10_5114_dr_2019_83445 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0033-2526&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0033-2526&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0033-2526&client=summon |